北美癌症疫苗市场预测至 2027 年 - COVID-19 影响和区域技术分析（树突状细胞癌症疫苗、重组癌症疫苗、抗原癌症疫苗、全细胞癌症疫苗、病毒载体癌症疫苗）；类型（预防性癌症疫苗、治疗性癌症疫苗）；适应症（宫颈癌、前列腺癌、其他适应症）；最终用户（儿科、成人）以及国家和地理
No. of Pages: 164 | Report Code: TIPRE00015129 | Category: Life Sciences
No. of Pages: 164 | Report Code: TIPRE00015129 | Category: Life Sciences
本研究报告提供了对全球癌症疫苗市场的见解。癌症疫苗是一种治疗现有癌症或预防癌症发展的疫苗。已建立的癌症治疗疫苗被称为治疗性癌症疫苗。一些/许多疫苗是“自体”的，由患者样本制成，并且是该患者所独有的。此外，癌症疫苗可以有两种类型：治疗性疫苗和预防性疫苗。例如，Cervarix、Gardasil、Gardasil-9 和乙型肝炎 (HBV) 疫苗 (HEPLISAV-B) 都是预防性癌症疫苗。而卡介苗 (BCG)、Sipuleucel-T (Provenge) 都是治疗性癌症疫苗
北美癌症疫苗市场预计将从 2019 年的 18.757 亿美元增至 2027 年的 66.236 亿美元。预计该市场将以2020 年至 2027 年复合年增长率为 17.5%。推动市场增长的因素包括全球癌症患病率的增加，以及全球健康研究组织和癌症疫苗主要参与者采取的举措。由于供应链中断和锁定条件。然而，癌症疫苗行业面临的挑战，如癌症疫苗成本较高，限制了市场的增长。
从技术角度来看，重组癌症疫苗领域在2019年占据了最大的市场份额；预计在预测期内将达到市场上最高的复合年增长率。从类型来看，预防性癌症疫苗领域在 2019 年占据了较大的市场份额，预计在预测期内也将在市场上占据更高的市场份额。同样，就最终用户而言，儿科细分市场在 2019 年占据了更大的市场份额，预计在预测期内市场复合年增长率更高。
世界健康组织 (WHO)、食品药品监督管理局 (FDA)、疾病控制与预防中心 (CDC) 和加拿大医疗技术制造商协会联盟是报告中包含的北美癌症疫苗市场的一些主要主要和次要来源。
Strategic insights for North America Cancer Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,875.7 Million |
| Market Size by 2027 | US$ 6,623.6 Million |
| Global CAGR (2020 - 2027) | 17.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Cancer Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Cancer Vaccines Market
The North America Cancer Vaccines Market is valued at US$ 1,875.7 Million in 2019, it is projected to reach US$ 6,623.6 Million by 2027.
As per our report North America Cancer Vaccines Market, the market size is valued at US$ 1,875.7 Million in 2019, projecting it to reach US$ 6,623.6 Million by 2027. This translates to a CAGR of approximately 17.5% during the forecast period.
The North America Cancer Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cancer Vaccines Market report:
The North America Cancer Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cancer Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cancer Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Cancer Vaccines Market
